Imint Launches Powerful Video Stabilization Technology to Enhance Training and Remote Collaboration Within the Healthcare Industry

IMINT Image Intelligence AB(“Imint”), a global leader in video enhancement software, today launched Vidhance for Remote Assistance, a new suite of subscription-based tools designed to transform the quality of video content captured by remote assistance devices used in the healthcare industry for training and remote collaboration.
The new solution consists of the Vidhance Premium Video Stabilization feature, setting a new industry standard for unrivaled video stability, and the all-new Vidhance Click & Lock feature, empowering remote viewers to effortlessly select, track, and focus on on-screen objects regardless of camera movement.“
Remote assistance devices are indispensable for real-time collaboration among healthcare professionals–whether it’s traveling surgeon training students in Africa, or on-site nurse providing wound care while relying on remote support from an expert doctor in another country,” said Niclas Elvgren, Head of the Professional Solutions Business Unit at Imint.“Drawing upon our deep expertise in the smartphone video enhancement market, we’ve developed Vidhance for Remote Assistance to simplify the path for independent software vendors and solutions providers to enhance communication and control for healthcare scenarios, even where the movements of wearers are unstable.”
The Vidhance Premium Video Stabilization feature efficiently eliminates shakiness in real-time by keeping the frame stable and the horizon level for video captured on handheld, head-mounted, or body-worn cameras, while also correcting for lens distortions. The software achieves this feat by leveraging data from the camera’s motion sensors to calculate the optimal stabilization frame-by-frame –a robust and efficient method that has been battle-proven in over 850 million smartphones powered by Imint to date.
In addition to stabilizing and leveling the video stream, the Vidhance for Remote Assistance solution also provides remote viewers direct control over the video’s focus point through the all-new Vidhance Click & Lock feature. With a simple click, remote viewers can select an object on the live feed to lock onto it as the camera’s focus point, using automatic tracking and zooming to center the object regardless of how it or the camera wearer moves.
Vidhancefor Remote Assistance is offered through a subscription model that is completely free to developers. Solution providers that integrate the software suite can provide a free trial period for users, then offer a monthly or annual subscription for full-time adoption.
“We chose a convenient subscription model for these powerful video enhancement features because we want them to be available to all levels of developers to help foster further innovation,” Elvgren added. “Asthe remote assistance needs of healthcare professionals continue to evolve, we’re fully committed to developing new solutions that will enhance the communication between healthcare professionals through high-quality video, thus paving the way for mass market adoption.
”The Vidhance SDK has been developed to allow flexible implementation in the video pipeline from camera to viewer. Imint has a proven track record in the smartphone industry, partnering with many of the market’s most innovative companies to bring improved video performance to millions of smartphone users. Furthermore, Imint is also emerging as the video stabilization leader in the wearables market through collaboration with brands such as RealWear and Rokid.
For more information about Vidhancefor Remote Assistance, visit here.
Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modificatio. Analysis of 72 patients treated in STK-001 clinical trials suggests that higher STK-001 drug exposure in brain leads to greater seizure reductions. Two-year data from the longest prospective natural history study of Dravet syndrome showed that, on average, patients experienced no meaningful improvement in convulsive seizure frequency and exhibited widening gaps in cognition and behavior despite treatment with the best available anti-seizure medicines.
"Exact Sciences is looking forward to presenting new evidence at SABCS that adds important perspectives to treating breast cancer patients and showing that some patients may be able to de-escalate treatments and still have positive outcomes," said Dr. Rick Baehner, Chief Medical Officer, Precision Oncology, Exact Sciences. "Every year, we build upon the precedent set by the Oncotype DX Breast Recurrence Score® test and its prognostic and predictive abilities to determine the chemotherapy benefit for specific breast cancer patients. We are pleased to see authorities expanding access to this test as we continue to develop key evidence in collaboration with some of the world's most prestigious, breast cancer-focused organizations."
Clozapine has been established as the most effective antipsychotic medication for treatment-resistant schizophrenia. However, it is significantly underutilized mainly due to the risk of developing agranulocytosis and the need to frequently monitor the absolute neutrophil count (ANC).
Dagi-Ben Noon, CEO of Inspira Technologies, reflects on the partnership's significance: "By Integrating our technology to oxygenate blood directly with Ennocure's infection prevention solutions, we are focusing on potentially improving patient outcomes in ICUs and paving the way for safer, more effective life-support treatments. This collaboration is expected to accelerate the development and broaden the implementation of our advanced technology."
The findings suggest that the novel, non-invasive genomic test can help physicians guide next steps for these patients, enabling them to potentially avoid unnecessary invasive procedures or accelerate time to appropriate treatment.

By using this website you agree to accept Medical Device News Magazine Privacy Policy